Abstract

Background: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most frequent epidermotropic cutaneous T-cell lymphomas (CTCL), both originating from CD4+ lymphocytes. There is no curative treatment for these orphan diseases, healing is rare and 25% may progress to higher stage disease. Although the malignant and reactive lymphocytes were studied extensively, little is known about the role of the dermal-epidermal microenvironment in MF and SS. The group of Hodak et al proposed an important role of dermal fibroblasts, but our knowledge on other dermal components is poor.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call